Tilt Investment Management Holdings, Pbc Regeneron Pharmaceuticals, Inc. Transaction History
Tilt Investment Management Holdings, Pbc
- $92.6 Billion
- Q4 2023
A detailed history of Tilt Investment Management Holdings, Pbc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tilt Investment Management Holdings, Pbc holds 437 shares of REGN stock, worth $468,079. This represents 0.41% of its overall portfolio holdings.
Number of Shares
437
Previous 566
22.79%
Holding current value
$468,079
Previous $466 Million
17.6%
% of portfolio
0.41%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,430Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.57 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$9.18 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.28 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.19 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.99 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $115B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...